Trial Profile

NEUPRO OL, Efficacy profile of Neurexan in an experimental acute stress setting – an explorative open-label study in healthy probands

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Avena sativa/coffea/passiflora incarnata/zincum valerianicum (Primary)
Indications Anxiety disorders; Sleep disorders
Focus Biomarker; Pharmacokinetics
Acronyms NEUPRO-OL

Most Recent Events

11 Feb 2015 Biomarkers information updated
01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
10 Oct 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01703832)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com